At a glance
- Originator Yamanouchi
- Class Antivirals; Small molecules
- Mechanism of Action Human immunodeficiency virus tat gene product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 31 Jul 1998 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 29 Oct 1996 New profile